Dr. Mease reported financial relation ships with UCB, which markets certolizumab. In addition, as a clinical trialist he has financial relationships with numerous other pharmaceutical companies that are interested in rheumatologic diseases.
FROM THE ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY